Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Foundation to Support Cell Transplant Research Launches Official Informational Web Site

By LabMedica International staff writers
Posted on 30 Apr 2009
A new Internet presence has been initiated that has been designed to increase awareness and further funding for stem cell transplant research.

The U.S. More...
National Foundation to Support Cell Transplant Research (NFCTR; Louisville, KY, USA) has launched its official web site to promote and support adult stem cell transplant research. Founded in late 2005, the NFCTR promotes and funds peer-reviewed research and early stage clinical trials in the field of adult stem cell research. By supporting both collaboration and information-sharing in a number of strong academic settings, the NFCTR works to create networking opportunities that readily utilize and expedite the science.

The NFCTR believes that funding ground-breaking research in multiple qualified institutions has unlimited potential to further the field of adult stem cell transplantation and develop new treatments for a large number of diseases and conditions affecting people worldwide. "The potential for curative therapies afforded by adult stem cell research is extremely promising," stated Dr. Paula P. Grisanti, cofounder and chairman of the NFCTR, "and we are fully committed to supporting and funding this critical research. It is our hope that this new web site will help to increase public awareness and generate the support required to fund these important studies."

People worldwide--many of them children or young adults--may benefit from these promising adult stem cell therapies. "This research has far-reaching implications for the treatment of many types of disease," added board of directors member Dennis Riggs. "Success, even at a modest level, may ultimately affect a large number of people on every continent...perhaps a close friend or family member...or maybe even yourself. It touches everyone."

NFCTR was founded by a small group of individuals--each personally impacted by the potential for this critical research. Stem cell research has the potential to revolutionize the treatment of a large number of diseases and conditions affecting people worldwide.

Related Links:
National Foundation to Support Cell Transplant Research



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.